Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit
February 28 2008 - 12:03PM
PR Newswire (US)
Company Brings Together Distinguished Panel of Dental Experts to
Advance the Art, Science and Knowledge of CCLAD in Dentistry
LIVINGSTON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today reported that
earlier this month the Company hosted the First International
Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit in New
Orleans. The Summit welcomed a distinguished panel of dental
experts who gathered to discuss advancements in the scientific and
clinical practice communities toward the common goal of advancing
the art, science and knowledge of CCLAD in dentistry. Joe Martin,
Chief Executive Officer of Milestone, noted, "Through this Summit,
Milestone hoped to provide a forum for open and objective
discussion by a unique blend of academia, key opinion leaders and
practicing dentists. The in-depth discussion, debate and exchange
of ideas that occurred helped to provide Milestone with
confirmation that the STA(TM) System and the CompuDent(R) (formerly
known as The WAND(R)) are significant improvements over traditional
injection techniques." The two day Summit was chaired by noted
dental anesthetic expert, Stanley Malamed, DDS, Professor of
Anesthesia and Medicine School of Dentistry at the University of
Southern California School of Dentistry. Dr. Malamed is also a
Diplomate of the American Dental Board of Anesthesiology, as well
as a recipient of the Heidebrink Award from the American Dental
Society of Anesthesiology and the Horace Wells Award from the
International Federation of Dental Anesthesia Societies. He has
authored more than 100 scientific papers and 16 chapters in various
medical and dental journals and textbooks in the areas of physical
evaluation, emergency medicine, local anesthesia, sedation and
general anesthesia. In addition, Dr. Malamed is the author of three
widely used textbooks, published by CV Mosby: Handbook of Medical
Emergencies in the Dental Office (5th edition 2000); Handbook of
Local Anesthesia (4th edition 1997); and Sedation - a guide to
patient management (4th edition 2001). Summit presenting
participants also included: -- John Brescia, DDS, PC, President of
John J. Brescia, DDS, PC, a private dental practice in River
Forest, Illinois; -- Monika Daublaender, MD, DDS, Associate
Professor of Oral Surgery at Johannes Guttenberg University in
Germany; -- Martin Jablow, DMD, a partner in the firm of Dental
Technology Solutions and general dental practitioner in Woodbridge,
New Jersey; -- William Lieberman, DDS, a nationally recognized
pediatric dentist practicing in Red Bank, New Jersey; -- Peter
Loomer, DDS, PhD, Associate Professor of Clinical Periodontology at
the University of California at San Francisco School of Dentistry;
-- Alfred Reader, DDS, MS, Professor of Advanced Endodontics at
Ohio State University College of Dentistry; -- Kenneth Reed, DMD,
noted dental anesthesiologist and nationally recognized lecturer on
dental anesthesia; -- John Yagiela, DDS, PhD, Professor of
Anesthesiology, Diagnostic and Surgical Sciences at UCLA School of
Dentistry. This highly productive and interactive forum has yielded
a number of exciting ideas on how Milestone can integrate the STA
System not only into dental school curricula, but also extend the
message to the dental community and patients, alike. Martin stated,
"It was perhaps most gratifying to confirm that academics and
clinicians, alike, recognize the potentially profound impact that
Milestone's CCLAD technology is having on the practice of
dentistry." In February of last year, Milestone introduced to
market the STA System, a patented CCLAD system that incorporates
the "pressure force feedback" elements of Milestone's patented
CompuFlo(R) technology, thereby allowing dentists to administer
injections accurately and painlessly into the periodontal ligament
space, effectively anesthetizing a single tooth. The STA System is
also capable of performing all of the injections that can be done
with a conventional dental syringe, including the palatal-anterior
superior alveolar, anterior middle superior alveolar and inferior
alveolar nerve block. The STA System achieves all of these
injections predictably and reliably and additionally allows a new
and novel interactive injection technique to be performed called
the STA-Intraligamentary injection that identifies the correct
location and provides an almost immediate onset of profound
anesthesia to a single tooth. Milestone received FDA 510(k)
Pre-market Notification acceptance in August 2006 for the marketing
and sale of the highly anticipated STA System and has since named
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of
healthcare products and services to office-based practitioners in
the combined North American and European markets, as its exclusive
distributor in the United States and Canada. "In light of the
direction and recommendations to the dental community we have
derived from this Summit, Milestone looks forward to replicating
this event every year," concluded Martin. About Milestone
Scientific Inc. Headquartered in Livingston, New Jersey, Milestone
Scientific is engaged in pioneering proprietary, highly innovative
technological solutions for the medical and dental markets. Central
to the Company's IP platform and product development strategy is
its patented CompuFlo(TM) technology for the improved and painless
delivery of local anesthetic. Specifically, CompuFlo is a
computer-controlled, pressure sensitive infusion, perfusion,
suffusion and aspiration technology, which provides real-time
readouts of pressures, fluid densities and flow rates, enabling the
advanced delivery and removal of a wide array of fluids. The Single
Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia
delivery system which uses this technology provides dentists with
audible and visual signals as to in-tissue pressure. Milestone's
existing painless injection systems are currently sold in 25
countries. For more information on these and other innovative
Milestone products, please visit the Company's web site found at
http://www.milesci.com/. Safe Harbor Statement This press release
contains forward-looking statements regarding the timing and
financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are
based on assumptions involving judgments with respect to future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond Milestone's control. Some
of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected
revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes
in customer and market requirements and standards, and the risk
factors detailed from time to time in Milestone's periodic filings
with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report on Form 10-KSB for the year
ended December 31, 2006. The forward looking-statements in this
press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or
update publicly any forward-looking statements for any reason. FOR
MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications
Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist 407-585-1080 or via email at DATASOURCE: Milestone
Scientific Inc. CONTACT: Dodi Handy, President and CEO, or Daniel
Conway, Chief Strategist, both of Elite Financial Communications
Group, LLC, +1-407-585-1080, , for Milestone Scientific Inc. Web
site: http://www.milesci.com/
Copyright